07/31/2026 | Press release | Distributed by Public on 07/31/2026 03:33
A small group of mid-sized companies are hitting new highs even as the broader market stalls.
Strength in today's 52-week-high list is concentrated in Industrial Machinery & Supplies & Components and Pharmaceuticals, each with 2 names. As of Thursday, July 30, 15 Mid Cap stocks are at their strongest price of the last year. The largest is Illumina (ILMN), with a market value of about $31.4 billion.
The central question is how these stocks are finding new highs while the S&P 500 has returned -0.7% over the last month. The list below details the names.
The Biggest Names On The List
The table below shows the 10 largest of the 15 names, sorted by market capitalization, with returns over four windows:
| Tickers |
Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| ILMN | $31.4 Bil | 5.3% | 4.2% | 16.6% | 88.7% |
| LH | $26.0 Bil | 2.7% | 8.4% | 12.7% | 21.8% |
| BURL | $23.4 Bil | 0.3% | 9.6% | 17.5% | 32.7% |
| SN | $23.1 Bil | 2.6% | 12.0% | 7.3% | 37.8% |
| ARXS | $19.8 Bil | 15.3% | 14.8% | 6.2% | n/a |
| MGA | $19.4 Bil | 1.1% | 6.2% | 6.4% | 74.5% |
| NBIX | $18.6 Bil | 2.6% | 6.5% | 10.1% | 38.2% |
| IEX | $17.4 Bil | 1.9% | 5.2% | 3.3% | 28.1% |
| JLL | $16.9 Bil | 6.4% | 13.3% | 16.7% | 31.1% |
| DINO | $16.7 Bil | 2.7% | 3.8% | 32.7% | 112.9% |
A high price demands high growth.
Burlington Stores (BURL) and Illumina (ILMN) are two of the largest companies on the list, and both trade at high multiples. BURL trades at 37.4 times trailing earnings, supported by revenue that grew 10.6% over the last twelve months.
Illumina trades at a similar 36.8 times trailing earnings, but its revenue grew just 1.3% over the same period. While ILMN has a higher operating margin at 19.6%, the disparity in growth rates is notable for two stocks trading at similar valuations.
A new high is a starting point, not a conclusion.
A 52-week high means a stock is at its strongest price of the last year, and that strength can persist. But a price is not a verdict on the business itself. It is simply what the market is willing to pay today.
The disciplined next step is to examine whether the company's fundamentals, like revenue growth and margins, earn that valuation. A high can be the beginning of a longer run or a sign that expectations have run ahead of reality.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
One more pattern worth noticing: 6 of the 15 names are Health Care stocks. When a whole group is making new highs together, a health care ETF like VHT is one way to own the group's strength without betting on which single name leads it from here.
Strength Is A Clue. It Is Not A Plan
A stock at its 52-week high has momentum on its side, and momentum is a real force. It is also the most crowded signal in the market, and the difference between a run that lasts and one that tops is always the business underneath.
Checking that business, across thousands of names, is how the Trefis High Quality (HQ) Portfolio is assembled: roughly 30 companies that pass the quality screens, rebalanced on rules. It has a track record of outpacing a benchmark that combines all major indices - the S&P 500, S&P Mid-cap, and Russell 2000. Let the highs point; let the discipline decide.